Stockscreener 앱 받기
68.84
2.65%
1.78
전일 마감가:
$67.06
열려 있는:
$66.89
하루 거래량:
5.76M
Relative Volume:
2.83
시가총액:
$13.26B
수익:
$4.08B
순이익/손실:
$32.48M
주가수익비율:
36.42
EPS:
1.89
순현금흐름:
$16.80M
1주 성능:
+0.42%
1개월 성능:
-3.11%
6개월 성능:
+10.39%
1년 성능:
+13.30%
1일 변동 폭
$66.89
$69.11
1주일 범위
$66.33
$70.88
52주 변동 폭
$50.35
$83.95
인사이트 코퍼레이션 Stock (INCY) Company Profile
명칭
Incyte Corp
전화
(302) 498-6700
주소
1801 AUGUSTINE CUT-OFF, WILMINGTON, DE
INCY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INCY
Incyte Corp
|
68.84 | 13.26B | 4.08B | 32.48M | 16.80M | 0.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
인사이트 코퍼레이션 Stock (INCY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-17 | 개시 | UBS | Neutral |
| 2024-10-29 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-10-01 | 개시 | Wolfe Research | Outperform |
| 2024-09-18 | 다운그레이드 | Truist | Buy → Hold |
| 2024-07-02 | 다운그레이드 | BMO Capital Markets | Market Perform → Underperform |
| 2024-05-23 | 개시 | Deutsche Bank | Hold |
| 2024-04-23 | 개시 | Cantor Fitzgerald | Neutral |
| 2024-02-23 | 개시 | Jefferies | Buy |
| 2024-02-14 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2023-12-13 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2023-12-04 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2023-11-21 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-07-25 | 개시 | Citigroup | Buy |
| 2023-05-04 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-04-10 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-03-24 | 업그레이드 | SVB Securities | Underperform → Market Perform |
| 2023-01-31 | 개시 | Piper Sandler | Overweight |
| 2022-08-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-08-03 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2022-07-28 | 개시 | Wells Fargo | Equal Weight |
| 2022-02-09 | 다운그레이드 | SVB Leerink | Mkt Perform → Underperform |
| 2022-01-18 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
| 2021-07-20 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2021-02-10 | 다운그레이드 | SVB Leerink | Mkt Perform → Underperform |
| 2021-01-07 | 개시 | Truist | Buy |
| 2021-01-04 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-06-16 | 개시 | The Benchmark Company | Hold |
| 2020-05-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-04-29 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-04-01 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-03-24 | 재개 | William Blair | Outperform |
| 2020-03-13 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2020-02-04 | 재개 | BofA/Merrill | Neutral |
| 2020-01-03 | 재확인 | BMO Capital Markets | Market Perform |
| 2020-01-03 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2020-01-02 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-10-03 | 개시 | Mizuho | Buy |
| 2019-09-12 | 개시 | BMO Capital Markets | Market Perform |
| 2019-09-05 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-09-05 | 재개 | Morgan Stanley | Equal-Weight |
| 2019-09-05 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2019-05-21 | 개시 | Credit Suisse | Neutral |
| 2019-05-03 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2019-04-11 | 개시 | Stifel | Hold |
| 2019-04-03 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-01-24 | 업그레이드 | William Blair | Mkt Perform → Outperform |
모두보기
인사이트 코퍼레이션 주식(INCY)의 최신 뉴스
Incyte Co. (NASDAQ:INCY) Stock Position Lowered by Sanctuary Advisors LLC - MarketBeat
Incyte price target raised to $70 from $68 at Wells Fargo - Yahoo Finance
Incyte Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Incyte (NASDAQ:INCY) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
Analysts Set Incyte Co. (NASDAQ:INCY) Target Price at $76.18 - MarketBeat
Incyte Corp. stock outperforms competitors despite losses on the day - MarketWatch
Incyte Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Insider Selling: Incyte Co. (NASDAQ:INCY) Insider Sells 650 Shares of Stock - MarketBeat
Incyte corp principal accounting officer Tray Thomas sells $90,967 in stock - Investing.com
Incyte (NASDAQ:INCY) Earns Neutral Rating from Analysts at UBS Group - MarketBeat
Orion Portfolio Solutions LLC Purchases New Stake in Incyte Co. (NASDAQ:INCY) - MarketBeat
Wellington Management Group LLP Has $4.74 Million Stock Position in Incyte Co. (NASDAQ:INCY) - MarketBeat
Incyte to Present at Upcoming Investor Conference - Yahoo Finance
Incyte Corp. stock outperforms competitors on strong trading day - MarketWatch
Toronto Dominion Bank Purchases 7,812 Shares of Incyte Co. (NASDAQ:INCY) - MarketBeat
Incyte Co. (NASDAQ:INCY) Shares Sold by Public Employees Retirement System of Ohio - MarketBeat
Incyte's SWOT analysis: stock faces patent cliff as pipeline progress unfolds - Investing.com
Incyte (NASDAQ:INCY) Earns Outperform Rating from William Blair - MarketBeat
Vestcor Inc Has $174,000 Holdings in Incyte Co. (NASDAQ:INCY) - MarketBeat
Incyte Corp. stock underperforms Friday when compared to competitors - MarketWatch
Oppenheimer maintains $82 target on Incyte post-ASH updates - Investing.com
Incyte Co. (NASDAQ:INCY) Stake Boosted by National Bank of Canada FI - MarketBeat
Tri Ri Asset Management Corp Takes Position in Incyte Co. (NASDAQ:INCY) - MarketBeat
Continuum Advisory LLC Cuts Stock Position in Incyte Co. (NASDAQ:INCY) - MarketBeat
Tri Ri Asset Management Corp Makes New Investment in Incyte Co. (NASDAQ:INCY) - MarketBeat
Incyte's Late-stage NSCLC Study Meets Primary and Secondary Goals - MSN
Barclays PLC Boosts Stake in Incyte Co. (NASDAQ:INCY) - MarketBeat
Incyte Corp. stock rises Wednesday, still underperforms market - MarketWatch
Biotech Roundup: 3 Stocks to Watch - Schaeffers Research
Incyte Late-Breaking Tafasitamab (Monjuvi®) Data at ASH 2024 Demonstrate Significantly Improved Progression-Free Survival in Patients with Relapsed or Refractory Follicular Lymphoma - Yahoo Finance
Incyte reports positive Phase 3 data for Zynyz for lung cancer - MSN
Incyte (INCY) Stock Drops Amid Market Volatility - GuruFocus.com
Narrow-Moat Incyte's Hematology and Dermatology Platforms Drive Growth - Morningstar
Incyte reports positive Phase 3 data for Zynyz for lung cancer (NASDAQ:INCY) - Seeking Alpha
CURE Media Group announces winners of the 2024 MPN Heroes® Recognition Program - GlobeNewswire Inc.
Janus Henderson Group PLC Has $11.31 Million Stock Position in Incyte Co. (NASDAQ:INCY) - MarketBeat
State Street Corp Sells 300,240 Shares of Incyte Co. (NASDAQ:INCY) - MarketBeat
Quantinno Capital Management LP Has $4.49 Million Stake in Incyte Co. (NASDAQ:INCY) - MarketBeat
Royal London Asset Management Ltd. Decreases Stock Position in Incyte Co. (NASDAQ:INCY) - MarketBeat
Incyte gains amid takeover speculation - MSN
Incyte Announces Positive Results from Phase 3 Trial Evaluating Retifanlimab (Zynyz®) in Combination with Platinum-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer - Yahoo Finance
Incyte Corp. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Jacobs Levy Equity Management Inc. Trims Stock Holdings in Incyte Co. (NASDAQ:INCY) - MarketBeat
Incyte Co. (NASDAQ:INCY) Shares Sold by Fmr LLC - MarketBeat
Verition Fund Management LLC Buys Shares of 40,467 Incyte Co. (NASDAQ:INCY) - MarketBeat
Incyte Co. (NASDAQ:INCY) Shares Sold by Caisse DE Depot ET Placement DU Quebec - MarketBeat
Edgestream Partners L.P. Makes New Investment in Incyte Co. (NASDAQ:INCY) - MarketBeat
Erste Asset Management GmbH Buys New Shares in Incyte Co. (NASDAQ:INCY) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Decreases Stake in Incyte Co. (NASDAQ:INCY) - MarketBeat
Incyte Co. (NASDAQ:INCY) Shares Purchased by The Manufacturers Life Insurance Company - MarketBeat
인사이트 코퍼레이션 (INCY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
인사이트 코퍼레이션 주식 (INCY) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Tray Thomas | Principal Accounting Officer |
Dec 16 '24 |
Sale |
69.31 |
650 |
45,052 |
23,312 |
2.88%
1.02%
자본화:
|
볼륨(24시간):